Geisinger Wyoming Valley Medical Center named among best major teaching hospitals

Geisinger Wyoming Valley Medical Center was ranked No. 9 on Fortune/Merative’s 2022 “25 Top Teaching Hospitals” list. The rankings are based on public data sets including Medicare cost reports, Medicare Provider Analysis and Review data, and core measures and patient satisfaction data from the Centers for Medicare & Medicaid Services Hospital Compare website. 

Michelle Thompson, MD, chief education officer and vice dean for graduate medical education and designated institutional official, said, “It’s public affirmation recognizing the clinical leadership team and all Geisinger Wyoming Valley employees for their contributions and efforts leading to a top-quality hospital that allows for an exceptional educational experience for the many residents and students who work and learn here.”

According to Erika Fry, a senior writer at Fortune, Merative’s researchers found that hospitals achieving a ranking tend to share seven key characteristics, including:

These characteristics come as no surprise to Daniel Landesberg, Geisinger’s associate vice president for clinical operations. “At Geisinger Wyoming Valley, we are fortunate to have everything on Merative’s list – particularly excellent nurses and committed leadership that emphasizes innovation and technology,” he said. “Their energy and focus make our hospital the ideal place for residents and fellows to work and learn.”

Fortune also writes that the list, “represents those hospitals that held up best against the pandemic’s ongoing stress test. They achieved better results than peer institutions on performance indicators intended to measure clinical outcomes, operational efficiency, patient experience, and financial health. The study, which for this year evaluated 2,650 U.S. hospitals, relies on publicly available Medicare data for its analysis. The Top Hospitals list also considers an organization’s contributions to its community and equity of care.”

The list is a debut for Fortune/Merative because Fortune’s long-time research partner, IBM Watson Health, became a standalone company named Merative when it was purchased in 2022.